These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 30630704)

  • 41. Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis.
    Shakeel MK; Lu L; Cannon TD; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Walker EF; Mathalon DH; Bearden CE; Addington J
    Schizophr Res; 2019 Feb; 204():334-336. PubMed ID: 30181061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Social Cognition Abilities in Patients With Different Multiple Sclerosis Subtypes.
    Henry A; Tourbah A; Chaunu MP; Bakchine S; Montreuil M
    J Int Neuropsychol Soc; 2017 Sep; 23(8):653-664. PubMed ID: 28656885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized control trial to assess the efficacy of metacognitive training compared with a psycho-educational group in people with a recent-onset psychosis.
    Ochoa S; López-Carrilero R; Barrigón ML; Pousa E; Barajas A; Lorente-Rovira E; González-Higueras F; Grasa E; Ruiz-Delgado I; Cid J; Birulés I; Esteban-Pinos I; Casañas R; Luengo A; Torres-Hernández P; Corripio I; Montes-Gámez M; Beltran M; De Apraiz A; Domínguez-Sánchez L; Sánchez E; Llacer B; Pélaez T; Bogas JL; Moritz S;
    Psychol Med; 2017 Jul; 47(9):1573-1584. PubMed ID: 28166848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early cognitive basic symptoms are accompanied by neurocognitive impairment in patients with an 'at-risk mental state' for psychosis.
    Eisenacher S; Rausch F; Ainser F; Englisch S; Becker A; Mier D; Fenske S; Meyer-Lindenberg A; Kirsch P; Zink M
    Early Interv Psychiatry; 2018 Aug; 12(4):586-595. PubMed ID: 27169782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metacognitive Deficits Predict Impaired Insight in Schizophrenia Across Symptom Profiles: A Latent Class Analysis.
    Lysaker PH; Gagen E; Wright A; Vohs JL; Kukla M; Yanos PT; Hasson-Ohayon I
    Schizophr Bull; 2019 Jan; 45(1):48-56. PubMed ID: 30321433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intrinsic motivation as a mediator between metacognition deficits and impaired functioning in psychosis.
    Luther L; Firmin RL; Vohs JL; Buck KD; Rand KL; Lysaker PH
    Br J Clin Psychol; 2016 Sep; 55(3):332-47. PubMed ID: 26756621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
    Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
    Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emotion perception, non-social cognition and symptoms as predictors of theory of mind in schizophrenia.
    Vaskinn A; Andersson S; Østefjells T; Andreassen OA; Sundet K
    Compr Psychiatry; 2018 Aug; 85():1-7. PubMed ID: 29906670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Role of Personal Identity on Positive and Negative Symptoms in Psychosis: A Study Using the Repertory Grid Technique.
    García-Mieres H; Villaplana A; López-Carrilero R; Grasa E; Barajas A; Pousa E; Feixas G; Ochoa S
    Schizophr Bull; 2020 Apr; 46(3):572-580. PubMed ID: 32275754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The association of metacognition with emotion recognition and perspective taking in a Russian sample with psychosis.
    Lysaker PH; Chernov N; Moiseeva T; Sozinova M; Dmitryeva N; Alyoshin V; Kukla M; Wiesepape C; Karpenko O; Kostyuk G
    J Clin Psychol; 2021 Apr; 77(4):1034-1044. PubMed ID: 33085987
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metacognitive training for young subjects (MCT young version) in the early stages of psychosis: Is the duration of untreated psychosis a limiting factor?
    Ussorio D; Giusti L; Wittekind CE; Bianchini V; Malavolta M; Pollice R; Casacchia M; Roncone R
    Psychol Psychother; 2016 Mar; 89(1):50-65. PubMed ID: 25799999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metacognition and social cognition in schizophrenia: stability and relationship to concurrent and prospective symptom assessments.
    Hamm JA; Renard SB; Fogley RL; Leonhardt BL; Dimaggio G; Buck KD; Lysaker PH
    J Clin Psychol; 2012 Dec; 68(12):1303-12. PubMed ID: 22886716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influences on functional outcome and subjective recovery in individuals with and without First Episode Psychosis: A metacognitive model.
    Wright A; Fowler D; Greenwood K
    Psychiatry Res; 2020 Feb; 284():112643. PubMed ID: 31718807
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neural correlates of social cognitive introspective accuracy in schizophrenia.
    Pinkham AE; Klein HS; Hardaway GB; Kemp KC; Harvey PD
    Schizophr Res; 2018 Dec; 202():166-172. PubMed ID: 30077432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hot and cold executive functions in youth with psychotic symptoms.
    MacKenzie LE; Patterson VC; Zwicker A; Drobinin V; Fisher HL; Abidi S; Greve AN; Bagnell A; Propper L; Alda M; Pavlova B; Uher R
    Psychol Med; 2017 Dec; 47(16):2844-2853. PubMed ID: 28587688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metacognition and general functioning in patients with schizophrenia and a history of criminal behavior.
    Bo S; Kongerslev M; Dimaggio G; Lysaker PH; Abu-Akel A
    Psychiatry Res; 2015 Feb; 225(3):247-53. PubMed ID: 25582967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between metacognitive beliefs and psychosocial performance in at-risk states of psychosis and patients with first psychotic episodes.
    Brüne M; Drommelschmidt KA; Krüger-Özgürdal S; Juckel G
    Early Interv Psychiatry; 2019 Jun; 13(3):604-612. PubMed ID: 29314591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationship between insight and theory of mind in schizophrenia.
    Konstantakopoulos G; Ploumpidis D; Oulis P; Patrikelis P; Nikitopoulou S; Papadimitriou GN; David AS
    Schizophr Res; 2014 Jan; 152(1):217-22. PubMed ID: 24321712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
    Bolt LK; Amminger GP; Farhall J; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurocognition in schizophrenia: from prodrome to multi-episode illness.
    Corigliano V; De Carolis A; Trovini G; Dehning J; Di Pietro S; Curto M; Donato N; De Pisa E; Girardi P; Comparelli A
    Psychiatry Res; 2014 Dec; 220(1-2):129-34. PubMed ID: 25149131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.